Voyageur Pharmaceuticals VYYRF Stock
Voyageur Pharmaceuticals Price Chart
Voyageur Pharmaceuticals VYYRF Financial and Trading Overview
| Voyageur Pharmaceuticals stock price | 0.05 USD |
| Previous Close | 0.1 USD |
| Open | 0.05 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.05 - 0.05 USD |
| 52 Week Range | 0.01 - 0.1 USD |
| Volume | 23K USD |
| Avg. Volume | 2.09K USD |
| Market Cap | 7.02M USD |
| Beta (5Y Monthly) | 0.918229 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.01 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
VYYRF Valuation Measures
| Enterprise Value | 12.64M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 3.1117647 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -7.562 |
Trading Information
Voyageur Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | 0.918229 |
| 52-Week Change | -24.42% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.1 USD |
| 52 Week Low | 0.01 USD |
| 50-Day Moving Average | 0.05 USD |
| 200-Day Moving Average | 0.06 USD |
VYYRF Share Statistics
| Avg. Volume (3 month) | 2.09K USD |
| Avg. Daily Volume (10-Days) | 7.43K USD |
| Shares Outstanding | 132.7M |
| Float | 117.78M |
| Short Ratio | N/A |
| % Held by Insiders | 14.29% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | November 30, 2022 |
| Most Recent Quarter (mrq) | February 28, 2023 |
| Next Fiscal Year End | November 30, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -42.56% |
| Return on Equity (ttm) | -95.69% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -1671276 USD |
| Net Income Avi to Common (ttm) | -1880237 USD |
| Diluted EPS (ttm) | -0.02 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 657.89K USD |
| Total Cash Per Share (mrq) | 0.005 USD |
| Total Debt (mrq) | 25.52K USD |
| Total Debt/Equity (mrq) | 1.14 USD |
| Current Ratio (mrq) | 1.606 |
| Book Value Per Share (mrq) | 0.017 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -1865000 USD |
| Levered Free Cash Flow (ttm) | -982057 USD |
Profile of Voyageur Pharmaceuticals
| Country | United States |
| State | AB |
| City | Calgary |
| Address | Dome Tower 1600 |
| ZIP | T2P 2Z1 |
| Phone | 403 923 5944 |
| Website | https://voyageurpharmaceuticals.ca |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. Voyageur Pharmaceuticals Ltd. was founded in 2017 and is headquartered in Calgary, Canada.
Q&A For Voyageur Pharmaceuticals Stock
What is a current VYYRF stock price?
Voyageur Pharmaceuticals VYYRF stock price today per share is 0.05 USD.
How to purchase Voyageur Pharmaceuticals stock?
You can buy VYYRF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Voyageur Pharmaceuticals?
The stock symbol or ticker of Voyageur Pharmaceuticals is VYYRF.
Which industry does the Voyageur Pharmaceuticals company belong to?
The Voyageur Pharmaceuticals industry is Drug Manufacturers-Specialty & Generic.
How many shares does Voyageur Pharmaceuticals have in circulation?
The max supply of Voyageur Pharmaceuticals shares is 147.18M.
What is Voyageur Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
Voyageur Pharmaceuticals PE Ratio is now.
What was Voyageur Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
Voyageur Pharmaceuticals EPS is -0.01 USD over the trailing 12 months.
Which sector does the Voyageur Pharmaceuticals company belong to?
The Voyageur Pharmaceuticals sector is Healthcare.